Volume 59, Issue 1, Pages (January 2001)

Slides:



Advertisements
Similar presentations
Protein analysis and proteomics II Monday, 30 January 2006 Introduction to Bioinformatics DA McClellan
Advertisements

Volume 66, Issue 4, Pages (October 2004)
Volume 63, Issue 2, Pages (February 2003)
Volume 55, Issue 3, Pages (March 1999)
Volume 59, Issue 1, Pages (January 2001)
Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins  Norbert Busch, Frank Lammert, Siegfried.
Adenosine-induced apoptosis in glomerular mesangial cells
Volume 69, Issue 1, Pages (January 2006)
Lawrence J. Macala, John P. Hayslett, Joan I. Smallwood 
Volume 65, Issue 6, Pages (June 2004)
Characterization of assembly of recombinant type IV collagen α3, α4, and α5 chains in transfected cell strains  Takehiro Kobayashi, Makoto Uchiyama  Kidney.
Volume 7, Issue 8, Pages (August 2000)
Volume 64, Issue 2, Pages (August 2003)
Volume 60, Issue 1, Pages (July 2001)
Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats  K. Thelle, E.I. Christensen, H. Vorum,
Volume 68, Issue 4, Pages (October 2005)
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Volume 62, Issue 4, Pages (October 2002)
Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti- DNA antibody-induced IL-1β  S. Yung, R.C.W. Tsang, J.K.H. Leung,
Volume 68, Issue 6, Pages (December 2005)
Volume 59, Issue 1, Pages (January 2001)
Mechanism of microthrombosis in HUS
Volume 64, Issue 2, Pages (August 2003)
Shiga toxin 1 elicits diverse biologic responses in mesangial cells
Volume 67, Issue 2, Pages (February 2005)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Volume 65, Issue 6, Pages (June 2004)
Volume 68, Issue 4, Pages (October 2005)
Volume 80, Issue 12, Pages (December 2011)
Volume 67, Issue 5, Pages (May 2005)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Tetsuo Morioka, Jian Yao, Yasuhito Suzuki, Takashi Oite 
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
Volume 7, Issue 8, Pages (August 2000)
BMP-7 protects mesangial cells from injury by polymeric IgA
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Volume 67, Issue 2, Pages (February 2005)
Volume 60, Issue 3, Pages (September 2001)
Volume 75, Issue 12, Pages (June 2009)
Volume 59, Issue 3, Pages (March 2001)
Volume 56, Issue 1, Pages (July 1999)
Volume 57, Issue 5, Pages (May 2000)
Volume 66, Issue 4, Pages (October 2004)
Frank Eitner, Jürgen Floege  Kidney International 
Volume 77, Issue 5, Pages (March 2010)
Volume 85, Issue 3, Pages (March 2014)
Volume 75, Issue 12, Pages (June 2009)
Volume 68, Issue 2, Pages (August 2005)
Volume 71, Issue 11, Pages (June 2007)
John H. Wiessner, Linda Y. Hung, Neil S. Mandel  Kidney International 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 62, Issue 2, Pages (August 2002)
Md Nasimuzzaman, Danielle Lynn, Johannes CM van der Loo, Punam Malik 
Eva Balint, Cory F. Marshall, Dr Stuart M. Sprague 
Volume 60, Issue 3, Pages (September 2001)
Volume 69, Issue 8, Pages (April 2006)
Mechanisms of tubulointerstitial injury in IgA nephropathy
Volume 58, Issue 5, Pages (November 2000)
Volume 61, Issue 5, Pages (May 2002)
Lamivudine in hepatitis B-associated membranous nephropathy
Role of macromolecular IgA in IgA nephropathy
Nuclear factors, hs1,2 enhancer and IgA nephropathy
Irena Klodos, Mikael Esmann, Robert L. Post  Kidney International 
Volume 56, Pages S254-S255 (July 1999)
Volume 64, Issue 2, Pages (August 2003)
Volume 58, Issue 6, Pages (December 2000)
Volume 80, Issue 9, Pages (November 2011)
Volume 55, Issue 3, Pages (March 1999)
Volume 60, Issue 2, Pages (August 2001)
Presentation transcript:

Volume 59, Issue 1, Pages 277-285 (January 2001) Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy  Joseph C.K. Leung, Sydney C.W. Tang, Man Fai Lam, Tak Mao Chan, Kar Neng Lai  Kidney International  Volume 59, Issue 1, Pages 277-285 (January 2001) DOI: 10.1046/j.1523-1755.2001.00489.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Separation of jacalin-purified IgA1 by size exclusion chromatography with fast-protein liquid chromatography (FPLC). The protein concentration eluted from the column was express as OD 280 unit (○). One-milliliter fractions were collected and analyzed by ELISA for the content of IgA (•). Kidney International 2001 59, 277-285DOI: (10.1046/j.1523-1755.2001.00489.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Isoelectric focusing (IEF; upper) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; lower) analysis of purified pooled pIgA1 and mIgA1 fractions. Kidney International 2001 59, 277-285DOI: (10.1046/j.1523-1755.2001.00489.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Separation of polymeric pIgA1 (pIgA1; upper chromatogram) and monomeric IgA1 (mIgA1; lower chromatogram) by anion exchange chromatography with a Mono Q column. The fractions eluted with less than 0.4 mol/L NaCl were pooled as pIgA P1 or mIgA P1, and those fractions eluted with more than 0.4 mol/L NaCl were pooled as pIgA P2 and mIgA P2. Kidney International 2001 59, 277-285DOI: (10.1046/j.1523-1755.2001.00489.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 IgA1 content of purified pooled, Mono Q-separated IgA1 subfractions. The IgA1 level for subfractions pIgA P1, pIgA P2, and mIgA P1 were significantly higher in patients (▪) than controls (□); **P < 0.001. Kidney International 2001 59, 277-285DOI: (10.1046/j.1523-1755.2001.00489.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Binding of pooled Mono Q-separated IgA1 subfractions to cultured human mesangial cells (HMCs). Results were expressed as mean fluorescence intensity (MFI). pIgA1 subfractions (pIgA P1 and pIgA P2) bound more than mIgA1 subfractions to HMC. The binding for subfractions pIgA P1 and pIgA P2 were significantly higher in patients (▪) than controls (□); **P < 0.001. Kidney International 2001 59, 277-285DOI: (10.1046/j.1523-1755.2001.00489.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Binding of pIgA1 (•) and mIgA1 (▴) from patients with IgAN to cell lysates prepared from cultured HMCs. Upper chromatogram (A) shows the elution pattern from Mono Q column. Lower figure (B) represents the result of ELISA assay. Kidney International 2001 59, 277-285DOI: (10.1046/j.1523-1755.2001.00489.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 7 Binding of pIgA1 (A) and mIgA1 (B) from patients with IgAN (▪) or control (•) to cultured HMCs after preincubation with increasing dose of poly-L-lysine (μg/mL; solid line) or heparin (U/mL; dotted line). Kidney International 2001 59, 277-285DOI: (10.1046/j.1523-1755.2001.00489.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 8 Binding of pooled pIgA1 (A) or mIgA1 (B) in patients (▪) or control (□) to cultured HMCs after preincubating the cells with 5 μg/mL poly-L-lysine or 5 U/mL heparin. Results were expressed as mean fluorescence intensity (MFI). Poly-L-lysine significantly increased the binding of pIgA1 or mIgA1 in patients with IgAN, whereas heparin significantly decreased the binding (P < 0.001 in both cases). In all experimental conditions, the binding of IgA1 from patients with IgAN was significantly higher than that of controls (P < 0.001). Kidney International 2001 59, 277-285DOI: (10.1046/j.1523-1755.2001.00489.x) Copyright © 2001 International Society of Nephrology Terms and Conditions